A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 22,468 shares of BDX stock, worth $5.13 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
22,468
Previous 24,089 6.73%
Holding current value
$5.13 Million
Previous $5.63 Million 3.78%
% of portfolio
0.02%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$221.47 - $242.41 $359,002 - $392,946
-1,621 Reduced 6.73%
22,468 $5.42 Million
Q2 2024

Jul 26, 2024

SELL
$225.07 - $246.17 $3,826 - $4,184
-17 Reduced 0.07%
24,089 $5.63 Million
Q1 2024

Apr 24, 2024

SELL
$233.45 - $247.73 $81,007 - $85,962
-347 Reduced 1.42%
24,106 $5.97 Million
Q4 2023

Feb 09, 2024

SELL
$232.24 - $267.23 $317,472 - $365,303
-1,367 Reduced 5.29%
24,453 $5.96 Million
Q3 2023

Oct 24, 2023

BUY
$254.9 - $283.59 $218,959 - $243,603
859 Added 3.44%
25,820 $6.68 Million
Q2 2023

Jul 13, 2023

SELL
$238.39 - $265.32 $139,458 - $155,212
-585 Reduced 2.29%
24,961 $6.59 Million
Q1 2023

May 11, 2023

SELL
$229.71 - $259.35 $216,846 - $244,826
-944 Reduced 3.56%
25,546 $6.32 Million
Q4 2022

Feb 08, 2023

SELL
$218.29 - $256.91 $66,796 - $78,614
-306 Reduced 1.14%
26,490 $6.74 Million
Q3 2022

Oct 17, 2022

BUY
$51.03 - $264.23 $33,475 - $173,334
656 Added 2.51%
26,796 $5.97 Million
Q2 2022

Jul 13, 2022

BUY
$234.74 - $275.42 $243,894 - $286,161
1,039 Added 4.14%
26,140 $6.44 Million
Q1 2022

May 12, 2022

SELL
$243.64 - $270.48 $1.61 Million - $1.79 Million
-6,628 Reduced 20.89%
25,101 $6.51 Million
Q4 2021

Feb 03, 2022

BUY
$230.08 - $250.94 $528,953 - $576,911
2,299 Added 7.81%
31,729 $7.78 Million
Q3 2021

Nov 02, 2021

SELL
$232.72 - $256.47 $1.52 Million - $1.67 Million
-6,526 Reduced 18.15%
29,430 $7.06 Million
Q2 2021

Aug 10, 2021

BUY
$232.65 - $254.58 $1.07 Million - $1.17 Million
4,579 Added 14.59%
35,956 $8.53 Million
Q1 2021

May 07, 2021

BUY
$232.09 - $256.88 $874,515 - $967,923
3,768 Added 13.65%
31,377 $7.44 Million
Q4 2020

Feb 04, 2021

SELL
$221.92 - $245.94 $362,617 - $401,865
-1,634 Reduced 5.59%
27,609 $6.74 Million
Q3 2020

Oct 29, 2020

BUY
$215.77 - $276.76 $239,720 - $307,480
1,111 Added 3.95%
29,243 $6.64 Million
Q2 2020

Jul 27, 2020

BUY
$219.9 - $263.41 $240,570 - $288,170
1,094 Added 4.05%
28,132 $6.57 Million
Q1 2020

May 08, 2020

BUY
$195.69 - $279.01 $901,739 - $1.29 Million
4,608 Added 20.54%
27,038 $6.06 Million
Q4 2019

Feb 04, 2020

BUY
$236.45 - $266.82 $172,608 - $194,778
730 Added 3.36%
22,430 $5.95 Million
Q3 2019

Nov 06, 2019

SELL
$230.58 - $256.08 $39,429 - $43,789
-171 Reduced 0.78%
21,700 $5.36 Million
Q3 2019

Oct 28, 2019

SELL
$230.58 - $256.08 $20,521 - $22,791
-89 Reduced 0.41%
21,871 $5.4 Million
Q2 2019

Aug 15, 2019

SELL
$217.4 - $246.08 $980,908 - $1.11 Million
-4,512 Reduced 17.04%
21,960 $0
Q1 2019

May 08, 2019

BUY
$206.05 - $248.17 $24,519 - $29,532
119 Added 0.45%
26,472 $0
Q4 2018

Feb 05, 2019

BUY
$204.73 - $257.93 $199,816 - $251,739
976 Added 3.85%
26,353 $5.79 Million
Q3 2018

Nov 02, 2018

BUY
$233.07 - $256.0 $746,989 - $820,480
3,205 Added 14.46%
25,377 $0
Q2 2018

Aug 10, 2018

SELL
$208.1 - $233.85 $3,329 - $3,741
-16 Reduced 0.07%
22,172 $0
Q1 2018

May 09, 2018

SELL
$205.46 - $240.27 $245,730 - $287,362
-1,196 Reduced 5.11%
22,188 $0
Q4 2017

Feb 22, 2018

BUY
$189.0 - $222.64 $1.35 Million - $1.59 Million
7,145 Added 44.0%
23,384 $0
Q3 2017

Nov 07, 2017

BUY
$186.89 - $198.9 $384,619 - $409,336
2,058 Added 14.51%
16,239 $3.18 Million
Q2 2017

Aug 08, 2017

BUY
N/A
14,181
14,181 $2.77 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.